» Articles » PMID: 29104573

Endothelial Regulator of Calcineurin 1 Promotes Barrier Integrity and Modulates Histamine-Induced Barrier Dysfunction in Anaphylaxis

Abstract

Anaphylaxis, the most serious and life-threatening allergic reaction, produces the release of inflammatory mediators by mast cells and basophils. Regulator of calcineurin 1 (Rcan1) is a negative regulator of mast-cell degranulation. The action of mediators leads to vasodilation and an increase in vascular permeability, causing great loss of intravascular volume in a short time. Nevertheless, the molecular basis remains unexplored on the vascular level. We investigated Rcan1 expression induced by histamine, platelet-activating factor (PAF), and epinephrine in primary human vein (HV)-/artery (HA)-derived endothelial cells (ECs) and human dermal microvascular ECs (HMVEC-D). Vascular permeability was analyzed in human ECs with forced Rcan1 expression using Transwell migration assays and using Rcan1 knockout mice. Histamine, but neither PAF nor epinephrine, induced Rcan1-4 mRNA and protein expression in primary HV-ECs, HA-ECs, and HMVEC-D through histamine receptor 1 (H1R). These effects were prevented by pharmacological inhibition of calcineurin with cyclosporine A. Moreover, intravenous histamine administration increased Rcan1 expression in lung tissues of mice undergoing experimental anaphylaxis. Functional assays showed that overexpression of Rcan1 promotes barrier integrity, suggesting a role played by this molecule in vascular permeability. Consistent with these findings, models of subcutaneous and intravenous histamine-mediated fluid extravasation showed increased response in skin, aorta, and lungs of -deficient mice compared with wild-type animals. These findings reveal that endothelial Rcan1 is synthesized in response to histamine through a calcineurin-sensitive pathway and may reduce barrier breakdown, thus contributing to the strengthening of the endothelium and resistance to anaphylaxis. These new insights underscore its potential role as a regulator of sensitivity to anaphylaxis in humans.

Citing Articles

Novel mediator in anaphylaxis: decreased levels of miR-375-3p in serum and within extracellular vesicles of patients.

Nunez-Borque E, Fernandez-Bravo S, Rodriguez Del Rio P, Palacio-Garcia L, Di Giannatale A, Di Paolo V Front Immunol. 2023; 14:1209874.

PMID: 37965316 PMC: 10642912. DOI: 10.3389/fimmu.2023.1209874.


Changes in miroRNA-103 expression in wound margin tissue are related to wound healing of diabetes foot ulcers.

Zhao X, Xu M, Tang Y, Xie D, Wang Y, Chen M Int Wound J. 2022; 20(2):467-483.

PMID: 35837786 PMC: 9885465. DOI: 10.1111/iwj.13895.


Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis.

Nunez-Borque E, Fernandez-Bravo S, Yuste-Montalvo A, Esteban V Front Immunol. 2022; 13:836222.

PMID: 35371072 PMC: 8965328. DOI: 10.3389/fimmu.2022.836222.


Metabolic Consequences of IgE- and Non-IgE-Mediated Mast Cell Degranulation.

Mendoza R, Anderson C, Fudge D, Roede J, Brown J J Immunol. 2021; 207(11):2637-2648.

PMID: 34732470 PMC: 8612977. DOI: 10.4049/jimmunol.2001278.


State-of-the-Art on Biomarkers for Anaphylaxis in Obstetrics.

Simionescu A, Stanescu A, Popescu F Life (Basel). 2021; 11(9).

PMID: 34575019 PMC: 8467046. DOI: 10.3390/life11090870.


References
1.
Wawrzyniak M, Pich C, Gross B, Schutz F, Fleury S, Quemener S . Endothelial, but not smooth muscle, peroxisome proliferator-activated receptor β/δ regulates vascular permeability and anaphylaxis. J Allergy Clin Immunol. 2015; 135(6):1625-35.e5. DOI: 10.1016/j.jaci.2014.11.006. View

2.
Saenz G, Hovanessian R, Gisis A, Medh R . Glucocorticoid-mediated co-regulation of RCAN1-1, E4BP4 and BIM in human leukemia cells susceptible to apoptosis. Biochem Biophys Res Commun. 2015; 463(4):1291-6. PMC: 4497928. DOI: 10.1016/j.bbrc.2015.06.106. View

3.
Ashraf M, Murakami M, Kudo I . Cross-linking of the high-affinity IgE receptor induces the expression of cyclo-oxygenase 2 and attendant prostaglandin generation requiring interleukin 10 and interleukin 1 beta in mouse cultured mast cells. Biochem J. 1996; 320 ( Pt 3):965-73. PMC: 1218022. DOI: 10.1042/bj3200965. View

4.
Rigor R, Shen Q, Pivetti C, Wu M, Yuan S . Myosin light chain kinase signaling in endothelial barrier dysfunction. Med Res Rev. 2012; 33(5):911-33. PMC: 3735785. DOI: 10.1002/med.21270. View

5.
Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P . Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest. 2006; 116(8):2244-51. PMC: 1523420. DOI: 10.1172/JCI25426. View